These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7042129)

  • 1. Deterioration of renal bone disease in patients treated with salmon calcitonin.
    Cundy T; Kanis JA; Heynen G; Paton S; Earnshaw M; Woods CG
    Clin Endocrinol (Oxf); 1982 Jan; 16(1):29-37. PubMed ID: 7042129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses to salmon calcitonin in chronic renal failure: relation to histological and biochemical indices of bone turnover.
    Cundy T; Heynen G; Gaspar S; Earnshaw M; Bartlett M; Paton S; Kanis JA
    Eur J Clin Invest; 1981 Jun; 11(3):177-84. PubMed ID: 6791936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity of endogenous and exogenous calcitonin in patients with osteitis fibrosa and chronic renal failure.
    Cundy T; Heynen G; Paton S; Ledingham JG; Russell RG; Oliver DO; Kanis JA
    Proc Eur Dial Transplant Assoc; 1978; 15():524-31. PubMed ID: 740683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
    Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
    Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.
    Andress DL; Norris KC; Coburn JW; Slatopolsky EA; Sherrard DJ
    N Engl J Med; 1989 Aug; 321(5):274-9. PubMed ID: 2631697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Paget's disease of bone with synthetic salmon calcitonin.
    Kanis JA; Horn DB; Scott RD; Strong JA
    Br Med J; 1974 Sep; 3(5933):727-31. PubMed ID: 4472416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute responsiveness to calcitonin in chronic renal failure.
    Cochran M; Hillyard CJ; Dew GJ; Martin TJ
    Br Med J; 1976 Aug; 2(6032):396-8. PubMed ID: 947443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
    Voigts AL; Felsenfeld AJ; Llach F
    Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermolability of alkaline phosphatase in the evaluation of renal osteodystrophy.
    Sagar S; Borra S; Kaye M
    Nephron; 1971; 8(3):270-7. PubMed ID: 5155279
    [No Abstract]   [Full Text] [Related]  

  • 10. Paget disease of bone. Long-term treatment with salmon calcitonin.
    Schuhmacher CA; Scurry MT; Deiss WP
    Arch Intern Med; 1973 May; 131(5):722-4. PubMed ID: 4735644
    [No Abstract]   [Full Text] [Related]  

  • 11. Arrest of hyperparathyroid bone disease with dihydrotachysterol in patients undergoing chronic hemodialysis.
    Kaye M; Chatterjee G; Cohen GF
    Ann Intern Med; 1970 Aug; 73(2):225-33. PubMed ID: 5311514
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of Paget's disease with salmon thyrocalcitonin. Cooperative double-blind study].
    Bouvet JP
    Nouv Presse Med; 1976 Apr; 6(17):1447-50. PubMed ID: 67592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in histologic and biochemical indexes of bone turnover after bilateral nephrectomy in patients on hemodialysis. Evidence for a possible role of endogenous calcitonin.
    Kanis JA; Earnshaw M; Heynen G; Ledingham JG; Oliver DO; Russell GG; Woods CG; Franchimont P; Gaspar S
    N Engl J Med; 1977 May; 296(19):1073-9. PubMed ID: 850517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic treatment of Paget's disease of bone with synthetic human calcitonin.
    Lang R; Milkman M; Jensen PS; Vignery AM
    Yale J Biol Med; 1981; 54(5):355-65. PubMed ID: 7336766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of Paget's disease of bone with salmon calcitonin (author's transl)].
    Kuhlencordt F; Ringe JD; Kruse HP
    Dtsch Med Wochenschr; 1981 Nov; 106(48):1620-3. PubMed ID: 7308002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic uses of calcitonin.
    Martin TJ
    Scott Med J; 1978 Apr; 23(2):161-5. PubMed ID: 644299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmon calcitonin in the treatment of bone metastases.
    Serdengeçti S; Serdengeçti K; Derman U; Berkarda B
    Int J Clin Pharmacol Res; 1986; 6(2):151-5. PubMed ID: 3721646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
    Trzenschik K; Schmidt UJ; Abendroth K; Ansorg H; Graner H; Lindenhayn K; Schramm G; Kalbe I
    Z Alternsforsch; 1978; 33(5):441-51. PubMed ID: 570764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC; Harrison JE; Wilson DR
    Can Med Assoc J; 1977 Nov; 117(9):1031-4. PubMed ID: 562231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human calcitonin treatment of Paget's disease of bone.
    Singer FR
    Clin Orthop Relat Res; 1977; (127):86-93. PubMed ID: 912995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.